MKI67 and breast carcinoma: The objective of the present study was to explore the discordance and prognostic impact of ER, PR, HER2, and Ki-67 expression in primary and recurrent/metastatic lesions in patients with primary early-stage breast cancer to obtain more evidence for clinical practice.